Heart muscle cells grown from patient stem cells—known as human induced pluripotent stem cell–derived cardiomyocytes, or ...

The U.S. Food and Drug Administration announced the approval of the first hematopoietic stem cell transplant therapy to treat ...

BOSTON and NEW YORK, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at Mount ...

A transplant of human stem cells sealed a hole in a monkey’s retina, which seems to have improved its vision, offering hope for a new approach to treat a type of age-related sight loss. As we age, a ...

Despite significant advancements in medical technology and procedural safety, the speaker emphasizes that relapse remains the ...

Stem-cell transplants with mismatched unrelated donors (MMUDs) beyond a single HLA locus (<7/8) had 1-year survival similar ...

Scientists at the University College London (UCL) have developed a novel therapy that helps treat patients with T cell acute ...

Ocata Therapeutics of Marlborough, which researches treatments for eye diseases, has agreed to be sold to Astellas Pharma Inc. of Japan for $379 million, the two companies announced late Monday.

Patient enrolment has been completed in Cynata's Phase 2 clinical trial of CYP-001 in acute graft versus host disease. The study has enrolled a total of 65 participants in the US, Europe and Australia ...

New biotech allows ‘seeds’ planted in the brain to differentiate into new nerve cells, reshaping its neural network.